Biotherapy Services
Biotherapy Services Limited is a multidisciplinary team of clinicians, scientists, pharmacists, and healthcare professionals focused on delivering safe and effective autologous biotherapies for wound healing and tissue regeneration. They utilize blood-derived products rich in white blood cells and platelets, harnessing the body's healing properties through state-of-the-art technology and proprietary processes to help patients in need. The company is involved in developing innovative treatments such as the RAPID™ Biodynamic Haematogel for complex and chronic wounds, including diabetic foot ulcers, pressure sores, and other non-healing wounds. They are engaged in clinical trials, regulatory approvals, and have received recognition such as the UK Innovation Passport. Their mission is to improve patient outcomes and reduce healthcare burdens through advanced regenerative therapies.
Industries
Nr. of Employees
small (1-50)
Biotherapy Services
Windsor, Windsor and Maidenhead, United Kingdom, Europe
Products
Autologous platelet‑rich gel wound treatment
A patient‑specific gel produced from concentrated autologous platelets and blood components, activated to release growth factors and applied topically to complex and chronic wounds to stimulate healing.
Autologous platelet‑rich gel wound treatment
A patient‑specific gel produced from concentrated autologous platelets and blood components, activated to release growth factors and applied topically to complex and chronic wounds to stimulate healing.
Services
Clinical trial execution for autologous wound therapies
Design, manage and operate randomized controlled clinical trials including multi‑site recruitment, clinical governance and trial treatment delivery for autologous wound care therapies.
Named‑patient access to investigational therapies
Respond to clinician requests to supply investigational autologous therapies for individual patients outside of trials, in accordance with national guidance on unlicensed medicinal products.
Mobile wound healing clinic service
Provide a mobile clinic service to deliver specialist wound care treatments and outreach services in non‑hospital settings.
Aesthetic and reconstructive PRP treatment services
Clinical provision of concentrated PRP formulations for aesthetic and reconstructive indications such as facial rejuvenation, scar revision, hair loss support and adjuncts to fat grafting.
Point‑of‑care manufacturing and regulatory compliance support
Provide point‑of‑care manufacture of autologous medicinal products under national manufacturing licences and maintain associated quality systems and accreditations.
Clinical trial execution for autologous wound therapies
Design, manage and operate randomized controlled clinical trials including multi‑site recruitment, clinical governance and trial treatment delivery for autologous wound care therapies.
Named‑patient access to investigational therapies
Respond to clinician requests to supply investigational autologous therapies for individual patients outside of trials, in accordance with national guidance on unlicensed medicinal products.
Mobile wound healing clinic service
Provide a mobile clinic service to deliver specialist wound care treatments and outreach services in non‑hospital settings.
Aesthetic and reconstructive PRP treatment services
Clinical provision of concentrated PRP formulations for aesthetic and reconstructive indications such as facial rejuvenation, scar revision, hair loss support and adjuncts to fat grafting.
Point‑of‑care manufacturing and regulatory compliance support
Provide point‑of‑care manufacture of autologous medicinal products under national manufacturing licences and maintain associated quality systems and accreditations.
Expertise Areas
- Clinical trial management for autologous therapies
- Point‑of‑care manufacturing of personalised medicines
- Autologous regenerative therapies (blood‑derived)
- GMP pharmaceutical manufacturing for clinical supply
Key Technologies
- Platelet‑rich plasma (PRP) processing
- Platelet‑rich fibrin / gel formulation
- Automated closed blood separation systems
- Sensor‑based cell‑type separation